<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 157 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page156.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=157">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 157 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 157</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=157"><img src="../thumb/157.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>126 / 2020-04                                             Cardio-Vascular Agents - 7.4.2 / 7.4.3 / 7.4.4 / 7.5
   hypoglycaem.sympt., discont.grad., physic. activ.limit.dur.withdr.pe-  Dosage: 5-20 mg 3xdly.as reqd. Max. 120 mg dly in div.dose.  Warnings and special precautions: Discont.if pregn. occurs/
   riod., bradycard. less than 50-55 beats/min., clonidine transf., eval.   Contraindications: Mark.anaem., head trauma, cerebr.haemorrh.,   contemplat., do not admin with another ACE inhibit./ARB, 36 hrs.to
                     nd
                   st
   risk:benef.ratio bef.admin.in pregn.esp.1  & 2  trimest., avoid anaes-  ac.coron.thrombos., incr.IC press., childr., pregn.(unless card.emerg.  elapse betw last dose of ACE/ARB or last dose of Entresto & init.ACE/
   thet.agents caus.myocard. depress.  when low. dose to be admin.), shock, hypoton.collapse, only un-  ARB, consid.adjust diuret./other concom. antihypertens.med.dos.&
   Drug interactions: Life-threat.eff.with concom. hypoglycaem.  der strict medic.supervis.for MI, ac.ang. pect. sympts.(10 mg tab.)  treat other hypotens. causes if hypotens.occurs, correct vol/Na de-
   agents, phenothiazines, class 1 anti-arrhythm., eff.counteract.by   Side effects: Headache, fac.flush., dizzin., tachycard., methaemo-  plet./ bef.init., discont./down titrat.if ren.funct.signif. decr., implement
                                                                                +
   sympathomimet., antihypertens.eff.reduc.by prostaglan.synthetase   globinaem., cold skin, imp. resp., bradycard., post.hypotens., drug   meas.to decr.any hyperkalaem., monit.ser.K in pts.at risk, discont.im-
   inhibit.e.g.ibuprofen & indomethacin, incr. hypotens. risk with cert.  rash, incr./ decr. in IOP of pts.with clos.angl.glauc., toler., paradox.S/E.  med.if angioed. report.& do not re-chall., incr.angio-oed. susceptibil.
   anaesth.agents & dihydropyridines, neg.inotrop.effs.poss.exagger.  Special precautions: Incr.dos.grad., poss. ischaem. card.pain/pe-  poss.in black pts., caut.with concom. statins/PDE-5 inhibit., no stud.
   by verapamil & diltiazem.    riph.ischaem.with rapid withdr.  in sev.hepat. impairm. theref.not recomm.,safety in pts.bel.18 yr.not
                                Drug interactions: Alcoh.may enhanc.hypotens. eff., act.of antihy-  est., low.start.dos in pts.over 65 yrs.
                                pertens.intensif., physiolog. antagon. to adrenaline, acetylcholine,   Drug interactions: Incr.system.expos.of statins, sildenafil incr.BP
                                                                                -
                                                                          -
                                                                                      -
   7.4.3   Organic nitrates     histamin.& other agents.      reduct., incr.ser.K+ lev with K-spar. diuret./K supplem.or Ksalt sub-
                                                              stit., NSAID’s incr.risk of worsen.ren.funct.& incr.BP, system. expos.
                                                              incr.with OATP1B1/ OATP1B3/ OAT3 inhibit. (eg rifampicin/ciclosporin)
   ISMO 20, Pharmaco [P/S]                                    or MPR2 (eg ritonavir).
   Isosorbide-5-mononitrate     7.4.4   Others                See also MDR page 550.
   Indications: Long-term ang.pect.prophylax.                 NIMOTOP, Bayer [P/S]
   (S3) TABS, R/7.1.4/136       CORALAN, Servier              Nimodipine.
   734055-005: 20 mg, 60, R283,48  Ivabradine                 Indications: Prophylax.& treatm.of ischaem. neurologic. defi-
   Dosage: Grad.incr.dos.to 1 tab.8-12 hrly.  Indications: Chron.stable ang.pect.in pts.with norm. sinus rhythm   cits caus.by cerebr.vasosp.follow. subarachn.haemorrh.of aneu-
   Contraindications: Hypoton.states of collapse, shock, pregn.  & heart rate ≥70 bpm as monother./in combinat. with beta-block.  rysmal origin
   Side effects: Headache, naus., dizz., tachycard., hypotens.  (also indic.in pts.already treat. with beta-block), to reduc.CV events   (S3) TABS, [P/S] T/7.1/229.
   Special precautions: Strict med.supervis.in ac. MI  in adults in sinus rhythm with mild to mod.symptomat.HF & heart   793353-009: 30 mg, 100, R1 192,99
   Drug interactions: Act.of hypertens.intensif.  rate of &gt;77 bpm in combinat.with std.ther.incl.beta-block./ when   Dosage: Follow.IV admin.2 tabs 4 hrly x21 days. Tot.dly dos: 360 mg.
   Warnings: Not for ac.sympts.  beta-block.C/I or not tol.   (S3) IV INFUS, [P/S] T/7.1/230.
   MONICOR 60 mg SR, Pharma Dynamics [P/S]  (S3) TABS. A39/7.1.4/0410, 0411  793361-001: 10 mg/50 ml, 1x50 ml, R439,28
                                710620-001: 5 mg, 56, R489,28
   Isosorbide-5-mononitrate     710621-001: 7,5 mg, 56, R489,28  Dosage: Admin.via 3-way stopcock into running drip using infus.
   Indications: Ang.pect.prophylax.                           pump via centr.cathet. Do not add to infus.bag/bottle/mix.with other
   (S3) SR TABS, A37/7.1.4/0340  Dosage: Coron.artery dis: Recomm.start.dos: 5 mg 2xdly. May   meds. Admin. x5-14 days,
                                be incr.aft.2-4 wks.to 7,5 mg 2xdly.depend.on therapeut. respons.
   710251-001: 60 mg, 30, R176,01                             For 1st 2 hrs.infus. 1 mg (i.e. 5 ml) each hr., incr. aft.2 hrs.to 2 mg/hr
   Dosage: Tab.may be brok.in half. Do not chew/ crush. As mono-  Titrat.dos. downwards.if heart rate decr.bel.50 bpm at rest/ sympts.  (i.e.10 ml about 30 µg/kg bm) provid.no decr.in BP observ.
                                relat.to bradycard.exper.
   ther.or in combin.with chron.beta-block.ther. Not indicat.for relief   For pts.with body mass of &lt;70 kg/unstable BP start with 0,5 mg/
   of ac.angin. attacks.        Chron.HF: Recomm.start.dos: 5 mg 2xdly. May be incr.aft.2 wks.  hr or less if necess.
                                to 7,5 mg 2xdly.if rest.heart persist.above 60 bpm or decr.to 2,5 mg
   Recomm.dos: 60 mg dly.in the morn.which may be incr.to 120 mg   Dos.reduct.reqd.and discont.consid.in sev.imp.liv. funct.
   once dly.in morn. May be init.at 30 mg dur.1  2-4 days.   2xdly.if rest.heart persist.below 50 bpm/bradycard. sympts. exper.  Prophylact.admin: Start.ther.no lat.than 4 days aft.haemorrh &
                     st
                                Contraindications: Pregn.& lactat., not stud. with rapid conduct.
   Contraindications: Sev.hypotens., hypovolaem., mark.anaem., HF   cont.dur.period of max.vasosp.risk. If haemorr.source treat.surgic.
   due to obstruct.incl.constrict. pericardit., rais.ICP due to head trauma/  disords.(ie.WPW), card. dysrhythm., sick sinus syndr., sino-atrial block,   cont.IV ther.x5 days post-op then contin.with oral admin.xfurth.7 days.
                                3  degr. AV block, pacemak.depend., rest.heart rate bel.70 bpm, sev.
                                 rd
   cerebr. haemorrh., angle clos.glauc., concom.sildenafil & other phos-  Therapeut.admin: If ischaem.neurologic.disturbs. caus. by vasosp.
   phodiesterase type 5 inhibit., not for ac.ang.attack, safety in pregn.   hypotens.&lt;90/50 mm Hg, cardiogen. shock, unstable/ac.HF, ac.coron.   aft.aneurysmal subarachnoid haemorrh. pres.treat as early as poss.
                                syndr., unstable ang.pect., concom.strong cytochrome P450 inhibit.,
   & lactat.not est., lact.intol.                             cont.for at least 5 days upto max.14 days then cont.with oral ther.
   Side effects: Drowsin., methaemoglobinaem., restlessn., blurr.   St John’s Wort, sev.liv. dysfunct., meds.prolong.QT-interv., immed.aft.   to complete 21 day treatm per. If haemorr. source treat.surgic.cont.
                                stroke, 2  degr.AV-block, no data avail.in childr. bel. 18 yrs., lact.intol.
                                    nd
   vis., tachycard., bradycard., dizzin., hypotens., syncope, sev./prolong.  IV ther.x5 days post-op.
   headache, imp.resp., GI disturbs., flush., cyanos., skin reacts., myalg.  Side effects: Trans.vis.sympts.mainly phosphenes. of mild to mod.  Contraindications: Safety in pregn.& lactat.not est., concom.ri-
                                intens., sinus bradycard., eosinophil., hyperuricaem., headache, diz-
   Warnings and special precautions: Incr.IOP in angl.clos.glauc.,   st  fampicin/phenytoin/phenobarb.& carbamazepine
   sev.cerebro.arterioscleros. & hypotens., sev.imp.ren./hepat.funct.,   zin., syncope, blurr.vis., vertigo, bradycard., AV 1  degr.block, ventricul.   Side effects: Hypotens., vasodilat., thrombocytopen., allerg.reacts.,
                                extrasystol., palpitat., supraventric. extrasystol., hypotens., dyspn., GI
   hypothyroid., malnutrit., hypotherm.                       rash, headache, hyperkines., tachycard., GI disturbs., bradycard., il-
   Drug interactions: Hypotens.eff.of alcoh./ vasodilat. & other hy-  disturbs., rash, erythema, prurit., musc.cramps, malaise, elev. creatin.  eus., loc reacts.with inj.admin., trans.incr.in liv.enzymes
                                Special precautions: Teratogen.in anim. studies & excret.in
   potens.meds.enhanc., sildenafil & other phosphodiesterase type   Special precautions: Imp.liv.funct.& discont.if hypotens.occurs, do
   5 inhibit. potent.eff.       breast milk, not recomm.in mod. liv.dysfunct., HF to be stable bef.  not admin.tabs & IV infus. concom., cerebr. oed., sev.rais.IC-press.,
                                consid. ther., heart rate below 50 bpm, discont.if heart rate bel.50
                                                              systol.BP &lt;100 mmHg, consid.potent.risk of reduc.coron. artery per-
   NITROCINE, GSK [P/S]         bpm.persists, concom.heart rate reduc. Ca chan.block.not recomm.,   fus.& myocard.ischaem.vs.benef.in unstable ang./within 1  4 wks.aft.
                                                                                     st
   Nitroglycerin                addit.effic.in combinat. with dihydropyridine Ca chan.block. not est.,   ac MI, monit. ren. funct.dur.treatm.with IV sol.in ren.dis./ nephrotox.
   Indications: Unrespons.systol.L-ventric.fail. second. to MI &   avoid with congenit.QT syndr.as QT prolongat. poss.exacerbat., not   drug use, due to alcoh.content of IV sol. poss.harmf.in alcohol./imp.
   unrespons.L-ventric.fail.in aetiolog. where afterload reduct.indic.,   recomm.in atrial fibrillat./ with other card.arrhythm.interfer.with sinus   alcoh.metabol./pregn./ breastfeed.childr./liv.dis./epilep.or alcoh. in-
   unstable ang.                node funct., reg.clinic.monit.for atrial fibrillat., eff.on vis.& retin.funct.  compat. meds., avoid grapefruit juice, poss.imp. sperm funct., IV sol.
   (S3) IV SOL, W/7.1/392. 1 mg/ml  beyond 1 yr unknown, discont.in unexpect.vis.funct. deteriorat., reti-  reacts with PVC, use polyethylene/ polypropylene dur.infus.,do not
   791776-018: 10x10 ml amps, R537,71  nitis pigmentosa, not recomm.in sev. aortic &/mitr.valvul.dis., poss.  substit. tubes supplied with IV sol.
   Dosage: Admin.undil.by slow IV infus/IV as admix. in NaCl/Dextr.   downward dos. titrat.with mod.CYP3A4 inhibit., concom. antipsychot.   Interactions: Rifampicin/phenytoin/phenobarb. & carbamazepine
   to reqd.concentrat.          & TCA’s, concom.amiodarone, elderly, creatinine clear.bel.15 ml/min.  reduc.effic., plasma conc.incr.by known inhibit.of cytochrome P450
   Indiv. Recomm.dos.range 10-50 µg/min.  Drug interactions: CYP3A4 inhibit.incr.plasma conc., CYP3A4   3A4, alcoh. content. may alt.other meds effs., incr.plasma conc. with
   Contraindications: Anaem., uncorrect. hypovolaem./ hypotens.,   induc.decr.plasma conc., grapefruit juice incr.expos., QT prolongat.  quinupristin/dalfopristin/cimetidine/ valproic acid, potent.hypotens.
   predisposit.to clos.angle glauc., rais.IC-press.due to head trauma/  of quinidine/ disopyramide/bepridil/sotalol & ibutilide exacerbat.  eff.of antihypertens., grapefruit juice may incr. plasma conc., IV ß-
   cerebr. haemorrh., constrict.pericardit.                   block. may lead to mutual potent.of negat. inotrop.act., high.plasma
   Side effects: Headaches, flush., N&V, hypotens., tachycard., ap-  conc.with fluoxetine, decr.plasma conc.with nortriptyline, high. zido-
   prehens., restlessn., musc. twitch., retrostern.discomfort, palpitat.,   vudine AUC with reduc.vol.distribut.& clear., potent.nephrotox.meds
   dizz., abdom.pain, paradox.bradycard., incr.IOP in clos.angle glauc.  7.5   Other vasodilators  poss.deterior. ren.funct.also if ren.funct.already impair.
   Special precautions: Hypothyroid., liv./ren.dis., hypotherm., mal-  ENTRESTO (MDR Listing)
   nutrit., monit.pulse & BP dur.infus.                       PROSTIN VR, Pfizer [P/S]
   Warnings: Incompat.with PVC infus.bags.  ENTRESTO, Novartis &  Alprostadil.
                                                              Indications: Palliat.ther.to temp.maint.patency of ductus ateriosus
   NITROLINGUAL, (Biopharma Div) Merck [P/S]  Sacubitril, valsartan  in neonates having duct.-depend. congenit.heart defect until correct./
                                       nd
   Nitroglycerin.               Indications: 2 -line ther.replac.ACE inhibit./ARB for symptomat.HF   palliat.surg. can be perform.
                                (NYHA class II-IV) in pts.with systol.dysfunct. Admin.in combinat.with
   Indications: Ang.pect.                                     (S4) INJ. Q/7.1/32. 0,5 mg/ml.
   (S3) SPRAY. P/7.1.4/281.     other HF ther.as appropr.     757802-028: 5x1 ml amps, R17,957,76
                                (S3) TABS. 50/7.6/1016, 1017, 1018
   787256-005: 0,4 mg/dos., 200 sngl.dos, R274,72             Dosage: 0,1 mcg/kg/min.by contin.IV infus.till desir.respon. Then
   Dosage: Dur.attack: 1-3 sprays/one attack und.tongue without   723103-001: (24/26 mg), 50 mg, 28, R802,39  decr.to lowest maint.dose.
                                723104-001: (49/51 mg), 100 mg, 28, R802,39
   inhal.within 2 mins.                                       Contraindications: Hyaline membr.dis.
   Prophylax.prior to physic.effort: a spray applicat.  723104-002: (49/51 mg), 100 mg, 56, R1 604,79  Side effects: Flush., bradycard., hypotens., tachycard., card.arrest,
                                723105-001: (97/103 mg), 200 mg, 56, R1 604,79
   Contraindications: Childr., pregn.(except emerg. at low.dos.), childr.,   oed., CHF , hyperaem., pneumopericardium, second degr.heart block,
   concom.sildenafil., organ. nitrate drug intol.  Dosage: Do not start ther.until 36 hrs.aft.discont. ACE inhib.ther.  shock, (R) ventr.infundibulum spasm, supra ventr. tachycard., ventr.
                                Start.dos.for pts.prev.using high dos.ACE/ ARB: 100 mg 2xdly.
   Side effects: Fac.flush., dizz., sev.headache & throbb., hypotens.,   fibrill.& ventr.hypertrophy, fev., apnoea, seiz., cerebr.bleed., neck hy-
   methaemoglobinaem.           Start.dos.for pts.curr.on low dos.ACE/ARB: 50 mg 2xdly. Dos.  perextens., hyperirrit., hypotherm., jitteriness, lethargy, microcepha-
   Special precautions: Mark.anaem., incr.IC-press., head trauma,   up titrat.by resembl.dos.every 3-4 wks.recomm.until targ.dos. of 200   ly, stiffn., bradyponea, bronch.wheez., hypercapn., hypoplast. lungs,
   cerebr.haemorrh., ac.coron. thrombos., clos.angle glauc., grad.withdr.  mg 2xdly achiev.of tol. Each dos.increm.to be preced.by hypotens./  pneumothorax, resp. depress./ distress, tachypnoea, diarrh., bil.
                                       +
   Drug interactions: Other drugs affect.CV syst., sildenafil potents   ren.funct.& ser.K  eval.  atresia, gastr. regurgitat., hyperbilirubinaem., dissem. intravasc. co-
   hypotens eff.                Contraindications: Concom.ACE inhibit, angioed. hist. relat.to prev.  agulat., hypochrom.anaem., thrombocytopen., bleed., anur., haema-
                                ACE inhib/ARB ther., hered./ idiopath. angioed, hypertroph.obstruct.
   SANDOZ ISOSORBIDE DINITRATE 5;10 Sandoz [P/S]  cardiomopathy, bil.ren.art.stenos., ren.arter. stenos. with sngl.kidn.,   tur., ren. fail., polycyst.kidn., sepsis, peritonit., hypo/ hyperkalaem.,
                                                              hypoglycaem., tachyphylax.
   Isosorbide dinitrate         aort.valve stenos., concom. K -spar. diuret., porphyr., Li ther., concom.  Warnings and special precautions: Bleed. tenden., monit ar-
                                            +
   Indications: Ac.ang.pect.attacks  ren. antagon. eg aliskiren, pregn.& lactat., sev.ren. funct. impairm.,   ter.press., ventilat., facilit.to be immed. avail., cortic.proliferat.of
   (S3) SUBLING. TABS, [P/S] W/7.1.4/336  concom.aliskiren/aliskiren cont. prod.  longbones (long-term infus.), gastric outlet obstruct.second.to an-
   784192-006: 5 mg, 50, R48,12  Side effects: Anaem., hypersens., hyper-/hypokalaem., hypogly-  tral hyperplas.
   Dosage: 1-2 tabs subling.2-3 hrly.  caem., dizzin., postur.dizzin., headache, vertigo, hypotens., syncope,
   (S3) TABS, [P/S] V/7.1.4/358  orthostat. hypotens., cough, diarrh., naus., gastrit., prurit., rash, an-  REVATIO, Pfizer [P/S]
   Indications: Ang.pect.prophylax.  gioed., ren.impairm., ren.fail., fatig., asthen., gynaecomast., fall, back   Sildenafil citr.
   784206-007: 10 mg, 50, R43,29  pain, influenza, nasopharyngit.  Indications: Pulm.arter.hypertens.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page156.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page152.html">152</a>&nbsp;&nbsp;&nbsp;<a href="page153.html">153</a>&nbsp;&nbsp;&nbsp;<a href="page154.html">154</a>&nbsp;&nbsp;&nbsp;<a href="page155.html">155</a>&nbsp;&nbsp;&nbsp;<a href="page156.html">156</a>&nbsp;&nbsp;&nbsp;<a href="page157.html">157</a>&nbsp;&nbsp;&nbsp;<a href="page158.html">158</a>&nbsp;&nbsp;&nbsp;<a href="page159.html">159</a>&nbsp;&nbsp;&nbsp;<a href="page160.html">160</a>&nbsp;&nbsp;&nbsp;<a href="page161.html">161</a>&nbsp;&nbsp;&nbsp;<a href="page162.html">162</a>
             </td>
             <td width="35%"><a href="page158.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page158.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
